Officials Warn Wildland Firefighters About Unapproved Glutathione Supplement for Smoke Exposure
Officials are warning wildland firefighters about the potential risks associated with using a glutathione supplement, administered via IV or nebulizer, to combat smoke exposure from wildfires. The supplement, which is not FDA-approved, has not been proven safe or effective, and…
Denver, CO, August 24, 2026 —
Authorities are issuing warnings to wildland firefighters regarding the use of a glutathione supplement, administered through intravenous (IV) drips or nebulizers, as a measure against smoke exposure during wildfire incidents.
The supplement in question has not received approval from the U.S. Food and Drug Administration (FDA). Furthermore, its safety and efficacy in mitigating the effects of wildfire smoke have not been scientifically established. Concerns have been raised about the potential for contamination during the manufacturing process of the glutathione product.
These concerns have led to significant actions, including recalls of the supplement by certain pharmacies. These recalls were prompted by the discovery of bacterial contamination within the product. Additionally, reports of adverse reactions experienced by individuals who have used the supplement have surfaced, further contributing to the cautionary stance taken by officials.
The use of unapproved substances, particularly those with potential contamination risks and unproven health benefits, poses a significant concern for the well-being of wildland firefighters, who operate in demanding and hazardous environments. The lack of FDA approval means that the supplement has not undergone the rigorous testing required to ensure its quality, safety, and effectiveness for public use.
Story summarized from the original created by The Associated Press on www.denver7.com, see more information here.
